COPD flare-up follow-up study
Part of Lungs & breathing clinical trials.
This study is for people with COPD who go to the emergency room for a moderate or severe flare-up. It looks at how they are doing after their visit and whether their current inhaler treatment is working well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older when you arrive at the ER.
- You have been diagnosed with COPD and are in the ER for a moderate or severe flare-up.
- A moderate flare-up means you need steroid pills, shots, or antibiotics.
- A severe flare-up means you need to stay in the hospital or be watched in the ER for more than 24 hours.
- You are already using a combination of two or three long-acting inhalers (like LABA/LAMA, LABA/ICS, LAMA/ICS, or all three).
- You do not have a tracheostomy, advanced cancer, lung transplant, or hospice care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well paramedics can evaluate a sudden worsening of COPD (a lung disease that makes it hard to breathe). It may help improve emergency care for COPD patients in the UMass Memorial system.
This study looks at people hospitalized for a COPD flare-up (“exacerbation”). It may help improve how flare-ups are treated because participants need to receive the usual rescue medicines like steroids and/or antibiotics and then follow a study plan.
This trial helps people with COPD who recently had a serious flare-up (worsening of breathing) by offering specialized follow-up care. The clinic aims to prevent future flare-ups and improve your health after an emergency visit.
This trial is looking at patients with a serious worsening of their chronic obstructive pulmonary disease (COPD) who need intensive care. It aims to gather information to help improve treatment for these severe episodes.
This observational study collects information on people with COPD (chronic lung disease) who have a severe flare requiring ICU care. It does not test a new drug, but the data may help doctors better understand severe COPD episodes and ICU outcomes.
This study looks at how well patients with COPD recover after an acute flare-up, and what symptoms or traits are most common. It aims to improve treatment and support for future patients.
Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.